Program
LTG-001
A development code. Also written as “LTG-001 High Dose”, “LTG-001 Mid Dose” and “LTG-001 Low Dose”.
Its studies are mostly in Pain, Postoperative · Acute Pain, led by Latigo Biotherapeutics.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Latigo Biotherapeutics | 41 open or running | phase 2since Dec 23, 2024 | Sep 15, 2023 | none ahead |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Sep 15, 2023First study: phase 1 study in HealthyFirst studyNCT06049095 · 204 enrolled · New Zealand
- Dec 23, 2024Phase 2 study in Pain, PostoperativeNCT06774625 · 250 enrolled · United States
- Jul 28, 2025Phase 2 study in Acute PainNCT07102459 · 343 enrolled · United States
- Dec 2, 2025Phase 1 study in AgnosiaNCT07341152 · 14 enrolled · United States
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 4 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07341152Agnosia · United States | 1 | Completed | Nov 17, 2025 | 14 |
| NCT07102459Acute Pain · United States | 2 | Completed | Jan 7, 2026 | 343 |
| NCT06774625Pain, Postoperative · United States | 2 | Completed | Aug 8, 2025 | 250 |
| NCT06049095Healthy · New Zealand | 1 | Active, not recruiting | Sep 2026 | 204 |
How it is read
Names in the registry
- “LTG-001”, 1 entry
- “LTG-001 High Dose”, 1 entry
- “LTG-001 Mid Dose”, 1 entry
- “LTG-001 Low Dose”, 1 entry
- “Experimental: LTG-001 High Dose”, 1 entry
Codes read as this program: LTG001.
Conditions, from the studies’ own filings
- Pain, Postoperative, 1 study
- Acute Pain, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.